Kokki Hannu, Ruuskanen A, Karvinen M
Department of Anesthesiology and Intensive Care, Kuopio University Hospital, Kuopio, Finland.
Acta Anaesthesiol Scand. 2002 Jul;46(6):647-53. doi: 10.1034/j.1399-6576.2002.460603.x.
Epidural analgesia provides outstanding pain relief after surgery, but it is also associated with numerous adverse effects. In order to improve postoperative pain management in children we determined whether the use of epinephrine added to epidural sufentanil-ropivacaine infusion reduced drug requirements, the intensity and duration of postoperative pain and the incidence and severity of adverse effects.
A prospective, randomized, double blind, parallel group study design was used in 61 children. The children were given continuous epidural sufentanil-ropivacaine infusion either with (n=32) or without (n=29) epinephrine for postoperative analgesia. Intravenous ketoprofen, a non-steroid anti-inflammatory drug, was used for all children, and epidural ropivacaine was used for rescue analgesia. The drug consumption, intensity of pain at rest and during activity, and all adverse effects were recorded.
: The need for sufentanil (P=0.001) and ropivacaine (P=0.006) was significantly lower in the with-epinephrine group than in the without-epinephrine group. The mean duration of epidural infusion (62 h) was similar in both groups. Four children in the without-epinephrine group were noticed to have a low oxygen saturation (SpO2<90%), and in one child a low respiratory rate (8 breaths min-1). The incidence of pruritus was higher in the without-epinephrine group (P=0.026).
Both infusions provided effective pain relief, and epinephrine as an adjuvant to continuous epidural sufentanil-ropivacaine infusion seems to be useful in children.
硬膜外镇痛在术后能提供出色的疼痛缓解效果,但也伴有众多不良反应。为改善儿童术后疼痛管理,我们确定在硬膜外舒芬太尼 - 罗哌卡因输注中添加肾上腺素是否能减少药物需求、术后疼痛的强度和持续时间以及不良反应的发生率和严重程度。
对61名儿童采用前瞻性、随机、双盲、平行组研究设计。儿童术后镇痛时,一组(n = 32)接受含肾上腺素的硬膜外舒芬太尼 - 罗哌卡因持续输注,另一组(n = 29)接受不含肾上腺素的输注。所有儿童均使用非甾体抗炎药静脉注射酮洛芬,硬膜外罗哌卡因用于补救镇痛。记录药物消耗量、静息和活动时的疼痛强度以及所有不良反应。
含肾上腺素组对舒芬太尼(P = 0.001)和罗哌卡因(P = 0.006)的需求显著低于不含肾上腺素组。两组硬膜外输注的平均持续时间(62小时)相似。不含肾上腺素组有4名儿童出现低氧饱和度(SpO2 < 90%),1名儿童呼吸频率低(8次/分钟)。不含肾上腺素组瘙痒发生率更高(P = 0.026)。
两种输注方式均能有效缓解疼痛,肾上腺素作为连续硬膜外舒芬太尼 - 罗哌卡因输注的佐剂在儿童中似乎有用。